Reimbursement and Access to Prescription Drugs Under Medicare Part B
Title | Reimbursement and Access to Prescription Drugs Under Medicare Part B PDF eBook |
Author | United States. Congress. Senate. Committee on Finance. Subcommittee on Health Care |
Publisher | |
Total Pages | 100 |
Release | 2002 |
Genre | Medical |
ISBN |
Rare Diseases and Orphan Products
Title | Rare Diseases and Orphan Products PDF eBook |
Author | Institute of Medicine |
Publisher | National Academies Press |
Total Pages | 442 |
Release | 2011-04-03 |
Genre | Medical |
ISBN | 0309158060 |
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
The Medicare Handbook
Title | The Medicare Handbook PDF eBook |
Author | |
Publisher | |
Total Pages | 60 |
Release | |
Genre | Health insurance |
ISBN |
Making Medicines Affordable
Title | Making Medicines Affordable PDF eBook |
Author | National Academies of Sciences, Engineering, and Medicine |
Publisher | National Academies Press |
Total Pages | 235 |
Release | 2018-03-01 |
Genre | Medical |
ISBN | 0309468086 |
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Coverage of Outpatient Prescription Drugs Under Medicare Part B
Title | Coverage of Outpatient Prescription Drugs Under Medicare Part B PDF eBook |
Author | United States. Congress. House. Committee on Ways and Means. Subcommittee on Health |
Publisher | |
Total Pages | 208 |
Release | 1988 |
Genre | Medicare |
ISBN |
Report to the President
Title | Report to the President PDF eBook |
Author | |
Publisher | |
Total Pages | 234 |
Release | 2000 |
Genre | Drugs |
ISBN |
On October 25,1999, the President directed the Secretary of Health and Human Services to study prescription drug costs and trends for Medicare beneficiaries. He asked that the study investigate: price differences for the most commonly used drugs for people with and without coverage; drug spending by people of various ages, as a percentage of income and of total health spending; and trends in drug expenditures by people of different ages, as a percentage of income and of total health spending. This report is the Department's response to that request. It represents the work of individuals and agencies throughout the Department, including the Agency for Healthcare Research and Quality (AHRQ), the Food and Drug Administration (FDA), the Health Care Financing Administration (HCFA), and the Office of the Assistant Secretary for Planning and Evaluation (ASPE).
Medicare Hospice Benefits
Title | Medicare Hospice Benefits PDF eBook |
Author | United States. Health Care Financing Administration |
Publisher | |
Total Pages | 6 |
Release | 1993 |
Genre | Hospice care |
ISBN |